CVS HealthCVSEarnings & Financial Report
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland.
CVS Q1 FY2026 Key Financial Metrics
Revenue
$100.4B
Gross Profit
N/A
Operating Profit
$4.7B
Net Profit
$3.0B
Gross Margin
N/A
Operating Margin
4.7%
Net Margin
2.9%
YoY Growth
6.2%
EPS
$2.30
CVS Health Q1 FY2026 Financial Summary
CVS Health reported revenue of $100.4B (up 6.2% YoY) for Q1 FY2026, with a net profit of $3.0B (up 65.9% YoY) (2.9% margin).
Key Financial Metrics
| Total Revenue | $100.4B |
|---|---|
| Net Profit | $3.0B |
| Gross Margin | N/A |
| Operating Margin | 4.7% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
CVS Health Q1 FY2026 revenue of $100.4B breaks down across 3 segments, led by Products at $62.2B (62.0% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $62.2B | 62.0% |
| Premiums | $33.8B | 33.6% |
| Services | $3.8B | 3.8% |
CVS Health Revenue by Segment — Quarterly Trend
CVS Health revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Premiums) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Products | $62.2B | — | — | $60.6B |
| Premiums | $33.8B | $34.0B | $33.7B | — |
| Services | $3.8B | $4.0B | $3.9B | $3.6B |
CVS Health Annual Revenue by Year
CVS Health annual revenue history includes year-by-year totals (for example, 2025 revenue was $402.1B).
CVS Health Quarterly Revenue & Net Profit History
CVS Health results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $100.4B | +6.2% | $3.0B | 2.9% |
| Q4 FY2025 | $105.7B | +8.2% | $2.9B | 2.8% |
| Q3 FY2025 | $102.9B | +7.8% | $-4.0B | -3.9% |
| Q2 FY2025 | $98.9B | +8.4% | $1.0B | 1.0% |
| Q1 FY2025 | $94.6B | +7.0% | $1.8B | 1.9% |
| Q4 FY2024 | $97.7B | +4.2% | $1.6B | 1.7% |
| Q3 FY2024 | $95.4B | +6.3% | $87.0M | 0.1% |
| Q2 FY2024 | $91.2B | +2.6% | $1.8B | 1.9% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $91.23B | $95.43B | $97.71B | $94.59B | $98.92B | $102.87B | $105.69B | $100.43B |
| YoY Growth | 2.6% | 6.3% | 4.2% | 7.0% | 8.4% | 7.8% | 8.2% | 6.2% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $252.48B | $252.43B | $253.22B | $255.59B | $258.34B | $255.33B | $253.54B | $252.97B |
| Liabilities | $177.37B | $177.32B | $177.49B | $178.47B | $180.79B | $182.22B | $178.16B | $175.34B |
| Equity | $74.93B | $74.94B | $75.56B | $76.93B | $77.38B | $72.93B | $75.21B | $77.64B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $3.09B | $-745.0M | $1.86B | $4.56B | $1.90B | $796.0M | $3.39B | $4.25B |